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   onsidering the importance of medication quality control and that mouthrinses for dental caries prevention have commonly
been prepared in dispensing pharmacies, this study assessed formulations containing 0.05% NaF acquired from 6 dispensing
pharmacies in the city of Piracicaba, S.P. The mouthrinse formulations were purchased in 3 separate periods and coded from A
to F. Fluoride ion (F-) concentration was determined in all formulations in the 3 periods, and in those acquired in the 3rd period,
the bioavailability of fluoride with dental enamel with caries-like lesions and the pH of products were evaluated. A solution of
0.05% NaF and distilled deionized water were used, respectively, as positive and negative controls. In the bioavailability
analysis, fluoride present in dental enamel was determined removing, by acid etching, two layers of enamel; fluoride in the acid
extract was determined with a specific electrode. The mouthrinses prepared in 5 pharmacies presented a F- concentration close
to the expected value, except for the product prepared in one of them, in which a mean of 0.01% NaF was found. All products
were more efficient than the negative control (p<0.05) in terms of reactivity with dental enamel, but differences among them
were observed with regard to the positive control (p<0.05). The data suggest that a quality control program should be
implemented in dispensing pharmacies to guarantee the quality of fluoridated mouthrinses formulated.
Uniterms: Dispensing pharmacy; Mouthrinse; Fluoride; Dental enamel; Bioavailability.
  onsiderando a importância do controle de qualidade de medicamentos e que os enxagüatórios bucais para prevenção da
cárie dental tem sido comumente preparados em farmácias de manipulação, este estudo avaliou enxagüatórios contendo NaF
0,05% adquiridos em 6 farmácias de manipulação na cidade de Piracicaba, SP. Os enxagüatórios foram adquiridos em 3 períodos
distintos e codificados de A a F. A concentração de fluoreto (F-) foi determinada em todas as soluções nos 3 períodos, e
naquelas adquiridas no 3o período, a biodisponibilidade do fluoreto com o esmalte dental com lesão de cárie artificial e o pH dos
produtos foram avaliados. Uma solução de NaF 0,05% e água destilada deionizada atuaram, respectivamente, como controle
positivo e negativo. Na análise de biodisponibilidade, fluoreto formado no esmalte dental foi determinado após remoção, por
ataque ácido, de 2 camadas de esmalte; fluoreto no extrato ácido foi determinado com eletrodo específico. Os enxagüatórios
preparados por 5 farmácias apresentaram uma concentração de F- próxima a esperada, com exceção do preparado por uma delas
no qual em média foi encontrado 0,01% NaF. Todos os produtos foram mais eficientes que o controle negativo (p<0,05) em
termos de reatividade com o esmalte dental, mas diferenças entre eles com relação ao controle positivo foram observadas
(p<0,05). Os dados sugerem que um programa de controle de qualidade deve ser implementado em farmácias de manipulação
para garantir a qualidade dos enxagüatórios fluoretados preparados.
Unitermos: Farmácia de manipulação; Enxagüatório; Fluoreto; Esmalte dentário; Biodisponibilidade.
www.fob.usp.br/revista or www.scielo.br/jaos
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INTRODUCTION
The quality of a pharmaceutical product is one of the
fundamental goals to be attained in a standard health system,
guaranteeing the patient’s benefit and safety. However,
errors in dispensing prescriptions have been reported in
France21 and in the United States28. Among these, the most
common errors are substitution of the medication on the
label and even in the composition28.
In Brazil there are also some reports of such problems
involving products purchased from dispensing pharmacies.
Zuccolotto, et al.33 found that 71.4% of the samples of phyto-
therapeutic products and vegetable inputs prepared in Porto
Alegre, RS, did not meet the minimum quality requirements
demanded by the Administrative Ruling No. 6 of the SVS-
MS (DOU 01/31/95)4. Another type of problem that may
occur is the interaction of the active agent with components
of the formula, resulting in inactivation or decrease of the
expected effect. Thus, Rocha, et al.25 reported that 1%
chlorexidine gel prepared in a dispensing pharmacy in
Piracicaba, SP, was ineffective in reducing the salivary levels
of mutans streptococci in patients rehabilited with removable
prostheses. The reason for this was explained, because
saccharine was used as sweetener and, at a concentration
greater than 0.5%, it inhibits the antibacterial activity of
chlorexidine digluconate at 1%10. Therefore, problems of
this nature may occur with other products prepared in
dispensing pharmacies. Currently, Brazilian dispensing
pharmacies are  adapting themselves to the regulation RDC
No. 33, of 04/19/20006.
Fluoridated mouthrinses are relevant as anti-caries
agents8. Among these, the 0.05% NaF mouthrinse for daily
use deserves to be mentioned, as it is efficient in controlling
caries in patients at high risk, as those under orthodontic
treatment12,23 or patients that have a physical or motor
handicap that prevents them from adequately controlling
dental plaque29. However, the efficacy of these products
does not depend only on the concentration of fluoride in
the formula, since the results of Franco and Cury14,15 showed
that the components of a commercial pre-brushing
mouthrinse reduced the reactivity of fluoride with human
dental enamel. One of the components of mouthrinses that
may reduce the reactivity of fluoride is the anionic detergent
sodium lauryl sulphate2, which competes with fluoride for
dental enamel surface3. Thus, problems with concentration
and fluoride activity of mouthrinses may occur both with
those prepared in dispensing pharmacies and with
commercial products.
In this context, Rodrigues, et al.26 evaluated the
concentration of fluoride ion (F-) in six commercial brands
of mouthrinses present in the Brazilian market, and found
that one of them did not comply with the regulation No. 79
of 08/28/2000 of the Ministry of Health’s National Sanitary
Surveillance Agency5, because of presenting around 39%
of the expected concentration (225 ppm F). This problem
with commercial mouthrinses was confirmed in another
evaluation11. Thus, if the products manufactured in Brazil
present problems with quality control, the doubt remains
when one considers the large number of dispensing
pharmacies and the amount of products they put onto the
market. Thus, the correct preparation of fluoridated
mouthrinses, considering their concentration, stability and
compatibility among components, should be assessed.
Therefore, this study aimed at evaluating mouthrinses
prepared in dispensing pharmacies, determining the
concentration and bioavailability of the fluoride present.
MATERIAL AND METHODS
Sampling and Experimental Design
Mouthrinses containing 0.05% NaF were purchased in 5
private dispensing pharmacies and in a School Pharmacy in
the city of Piracicaba, SP, at 3 separate periods. The private
pharmacies were chosen due to their central location in the
city and by the fact that two of them are responsible for 80%
of the market. In each period, a formula from each
establishment was purchased, made up from a prescription
given by a dentist, who was not related to the research. The
prescription specified the formulation of a fluoridated
mouthrinse containing 0.05% NaF. The products were coded
from A to F allowing a blind analysis and also ethically
preserving the names of the pharmacies. The concentration
of  F- ion was determined in all solutions in the 3 periods.
In addition, the pH of the products and the bioavailability
of the fluoride to dental enamel were also assessed in the
products purchased in the third period. A 0.05% NaF solution
was prepared in the laboratory and acted as positive control.
Ninety-six blocks of dental enamel with artificial caries lesions
were randomly divided into 8 groups of 12 and submitted to
the following treatments: distilled deionized water (negative
control), 0.05% NaF solution and the 6 fluoridated
mouthrinses purchased. The concentration of fluoride
present in dental enamel was assessed after removal of two
layers of enamel by acid etching, followed by an analysis of
the extract with a specific electrode.
Determination of pH and fluoride concentration
in mouthrinses
The pH of the products purchased in the third period
was determined using a pHmeter connected to a pH
electrode, which was calibrated against standard pH buffers
(pH 4.0 and 7.0). The products purchased and the solutions
prepared in the laboratory were diluted 20 times and TISAB
II (1.0 M acetate buffer, pH 5.0, containing 1.0 M NaCl and
CDTA at 0.4%) was added in the proportion of 1:126. The
analyses were made in triplicate (variation coefficient lower
than 1%). The determination of  F- was done with a specific
electrode ORION 96-06 and ion analyzer EA 940, previously
calibrated with standards containing 1.0 to 10.0 µg F/mL,
prepared from 100 ppm F standard (ORION 940907). This
analysis was made after each acquisition of products.
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Bioavailability of fluoride with dental enamel
For this evaluation, enamel with caries-like lesions was
used because this condition is more suitable in terms of the
dose-effect relationship than sound enamel32. Blocks of
dental enamel measuring 4 x 4 x 2mm were obtained16 from
sound bovine incisor teeth that had been stored in a 2%
formaldehyde solution (pH 7.0) at room temperature for at
least 30 days9,31.
The enamel surface of the blocks was measured (±
0.01mm), and the other surfaces were protected with a layer
of acid-resistant varnish. To produce subsurface caries-like
lesions, the enamel blocks were immersed for 16h in a 0.05M
sodium acetate buffer solution at 37ºC, pH 5.0, 50% saturated
in relation to bovine dental enamel24. After this period, the
enamel blocks were washed with distilled and deionized water
and stored in a humid and refrigerated environment (4°C).
Ninety-six blocks were randomly divided into eight groups
of 12 and submitted to the following treatments: six groups
for the fluoridated mouthrinses purchased from the
dispensing pharmacies and two groups for the positive
(0.05% NaF solution prepared in the laboratory) and negative
control (distilled deionized water). The reaction time was 10
minutes, the proportion of 1mL of solution/mm2 of exposed
enamel surface was standardized, and after the reaction the
blocks were washed for 1 min with distilled deionized water.
Two layers of enamel were consecutively removed from each
enamel block by immersion in 0.25mL of an aqueous solution
of 0.5M HCl for 15 and 30 seconds under agitation, followed
by buffering with the same volume of TISAB II pH 5.0
modified with 20g of NaOH/L19,22. In these extracts, fluoride
and inorganic phosphorous (Pi) concentrations were
determined. The determination of  F- was performed using
an ion analyzer ORION EA 940 and an ion specific electrode
ORION 96-09, previously calibrated with standards of 0.05
to 1.0µg F/mL. Pi was determined by the colorimetric method
of Fiske and Subbarow13. From the amount of Pi extracted
by the acid etching, the mass of enamel removed was
calculated, considering a Pi content in enamel of 17.4%
20.
Considering the amount of fluoride extracted (µg) and the
enamel mass (g), the concentration of fluoride in enamel
due to the treatments (µg/g) was calculated. An enamel
density of 3.020 was considered to calculate the thickness of
enamel removed (depth of the biopsy).
Statistical Analysis
The fluoride concentration data and the pH of the
mouthrinses were descriptively analyzed. The results of the
thickness of the two layers of enamel were evaluated by
analysis of variance (ANOVA). The results of fluoride in
enamel were transformed into log10, submitted to ANOVA
followed by Newman-Keuls test (p<0.05). For all these
analyses, the program BioEstat 2.01 was used and the
significance limit was established at 5%.
RESULTS
Table 1 shows that the mouthrinses prepared in most of
the pharmacies presented a fluoride concentration close to
the expected value (225ppm of  F-) in the formulas bought at
the separate periods. However, the same did not occur with
Pharmacy A. The first product purchased in this pharmacy
presented a concentration 5 times smaller than that expected.
The product prepared in the 2nd  period again presented a
lower fluoride concentration than that mentioned on the
label (0.05% NaF), which was 0.003% NaF. In the sample
prepared for the 3rd  time by Pharmacy A, the F- concentration
present was greater than that found in the previous ones,
but was still less than the concentration expected and
described on the product label. In the positive control
solution (NaF at 0.05%) prepared in the laboratory, 228.2µg
F/mL (ppm) was found. Table 1 also shows the results of the
pH of the six mouthrinses acquired in the 3rd period and
positive control solution, which ranged from 5.64 to 7.16.
Table 2 shows the results of fluoride concentration in
enamel after the reaction of the mouthrinses with the enamel
blocks, as well as those of the controls, in the two layers of
removed enamel. The ANOVA of fluoride in enamel showed
Pharmacy     Periods Mean ± sd pH
    1     2     3
Positive control 223.7 227.7 233.3 228.2 ± 4.8 6.07
A 40.7 12.2 97.0 50.0 ± 43.2 6.44
B 233.6 230.3 233.1 232.3 ± 1.8 5.64
C 223.4 233.5 231.3 229.4 ± 5.3 6.23
D 228.9 205.8 254.9 229.9 ± 24.6 6.88
E 231.5 243.1 204.4 226.3 ± 19.9 6.03
F 209.3 227.4 221.3 219.3 ± 9.2 7.16
*  Expected 225 (± 10%) µg/mL, accordingto Brazilian guidelines5 
TABLE 1-  Fluoride concentration* (µg/mL) found in the 3 formulas of the mouthrinses in each of the periods and mean (±
standard deviation) and pH of the mouthrinses purchased in the 3rd period
43
TABCHOURY C P M, PIEROBON C N, CURY J A
significance for the treatment in each layer (p<0.05). In the
1st  layer, all treatments showed differences when compared
to the negative control (p<0.05); the products prepared in
Pharmacies A, D and F presented reactivity equal to that of
the positive control, while those from Pharmacies B, C and E
presented statistically greater reactivity than that of the
positive control. In the 2nd  layer, the concentration of fluoride
in the enamel due to reaction with the negative control was
statistically different from that due to all other treatments,
except for the products from Pharmacies D and F (p>0.05).
The products prepared in Pharmacies B, C and E presented
reactivity similar to the positive control. The distance from
the surface of each enamel layer removed is shown as mean,
as the difference between the treatments was not statistically
significant (1st layer p= 0.5027; 2nd layer p=0.2392).
DISCUSSION
The findings showed that the fluoridated mouthrinses
purchased from the dispensing pharmacies presented
differences in their formulas (Table 1), as the product
prepared in Pharmacy A presented problems in its formula
with regard to fluoride concentration in the three periods
analyzed. Even though this fact was presented by only one
of the pharmacies, in terms of consumers’ rights this fact is
relevant even if it puts in risk the health of only one citizen.
Furthermore, this suggests that consumers are purchasing
products that have been manipulated in an incorrect manner.
These incorrectly dispensed products could include not
only the fluoridated mouthrinses herein presented, but also
other medications that are of indispensable use to the
patient. The cause of the error in preparing a 0.05% NaF
solution may include factors starting with impure raw material
through to the use of an un-calibrated balance. The problem
with raw material would be of lesser importance in
comparison with that of weighing, as the same balance may
be used for weighing other pharmaceutical substances. The
current legislation6 establishes that a dispensing pharmacy
must present a quality control laboratory to analyze, among
others, the amount of active substance, and the equipment
needs to be periodically verified and calibrated.
With regard to the capacity of fluoride present in the
mouthrinses to react with dental enamel (Table 2), all
products presented bioavailable fluoride ready to be
incorporated by enamel with caries-like lesions, including
that from Pharmacy A, which presented formulation problems
(Table 1), as all groups differed statistically from the negative
control (p<0.05). However, differences among the products
themselves and in relation to the positive control were
observed. Thus, some of these fluoridated mouthrinses,
whose fluoride concentration was close to that mentioned
on the label, presented statistically greater reactivity than
the positive control in the first layer of enamel removed, and
this result is surprising at a first glance. There may be two
explanations for the greater reactivity of the mouthrinses
prepared in Pharmacies B, C and E in relation to the positive
control: (1) these products would have a lower pH than the
fluoridated solution prepared in the laboratory, which would
positively influence the reactivity of fluoride with dental
enamel as, according to Saxegaard and Rölla27, the decrease
in pH of a solution of 0.48 mol/L NaF from 7.0 to 5.5 causes
an increase of 4 times in the reactivity of fluoride with dental
enamel. The pH of the different solutions analyzed was
determined and there was no relationship between lower
pH values and greater reactivity. The pH values of solutions
ranged from 5.64 (mouthrinse B) to 7.16 (mouthrinse F). This
may explain the greater reactivity of the mouthrinse B
(p<0.05), but, the pH of the positive control solution was
6.07 and the pH of mouthrinse C was 6.23, which would not
explain its greater reactivity (p<0.05).
Another explanation would be that the substances
present in the mouthrinses could increase fluoride reactivity.
There have been reports of increase of fluoride incorporation
in dental enamel in the presence of surface agents7,17.
Assessing the product labels in this study, it was noted
that Nipagin (methylparaben), a preservative, was listed in
the composition of the mouthrinses prepared in Pharmacies
B and C, exactly two of the three products that presented
greater reactivity. As methylparaben absorbs light at 250nm,
absorption spectra of the mouthrinses were traced in a
spectrophotometer. Those coded as B, C, E and a solution
of methylparaben at 0.2% prepared in the laboratory
presented similar spectras with a peak close to 250nm.
Mouthrinses A, D, F and the fluoridated solution prepared
in the laboratory, which contained only NaF, did not present
this peak at 250nm. Thus, the three mouthrinses, which
presented the greatest values of fluoride bioavailability with
dental enamel in relation to the first layer, also presented the
absorption spectra indicative of the presence of
methylparaben. These results suggest that new studies
should be carried out, in order to confirm this effect of
methylparaben and in addition, try to explain its mechanism
Treatment Distance from the surface (µm ± dp)
8.2 ± 2.2 (n=10) 25.5 ± 5.9 (n=11)
Negative
control 623.6 ±      75.8 a 599.1 ± 168.4 a
A 2735.6 ± 252.4 b 915.8 ± 165.4 bc
B 4174.2 ± 216.2 c 1582.3 ± 211.8 d
C 4548.9 ± 284.6 c 1802.5 ± 260.1 d
D 3148.9 ± 156.0 b 853.9 ± 123.4 abc
E 4740.2 ± 261.9 c 1385.8 ± 216.9 cd
F 2391.9 ± 121.5 b   745.8 ±   96.9 ab
Positive
control 2677.9 ± 169.4 b       1849.8 ± 619.6 d
TABLE 2-  Concentration (µg/g ± standard error) of fluoride
in dental enamel according to the treatments and the
removed layer
Treatments whose means are followed by different letters
differ statistically by the Newman-Keuls test (p<0.05).
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of action.
The results of greater fluoride bioavailability of the
products prepared in Pharmacies B, C and E were not
repeated in the second layer, suggesting that methylparaben
could only increase the amount of fluoride formed close to
the surface. This kind of fluoride formed could be “CaF2”-
like, which is considered the product responsible for the
anti-caries effect of the topical methods of fluoride use27,30.
Thus, research differentiating the type of fluoride formed in
dental enamel should be conducted.
CONCLUSION
In summary, the data suggest that most of the products
evaluated were adequately prepared and with bioavailable
F, but a process of quality control should be implemented in
dispensing pharmacies.
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